No continuing education is available.
|Date: March 4, 2022||Format: Webinar|
|Time: 11:30 AM—12:30 PM EST||
Cost: FREE Registration (Certificate of Attendance)
$25 Fee for Continuing Education Credits
|Note the CEU fee is for Maine Behavioral Health professionals to cover the cost of issuing those CEUs, for everyone else, when you register you can select the Free option and you will get a certificate of attendance.|
ABOUT THE LEARNING SESSION
New England PTTC will be co-Sponsoring the March installment of Maine’s Governor Janet Mills’ Opioid Response Summit Seminar Series, which will be focused on the topic of the intersection of brain injury and substance use disorder. The seminar is being conducted in partnership and featured speakers from the Maine/New Hampshire chapter of the Brain Injury Association of America.
Along with the epidemic of overdoses, there has been a parallel rise in sustained and often permanent cognitive disability resulting from a loss of oxygen to the brain. This webinar will provide an overview of the relationship between brain injury and substance use, and introduce the practical steps providers can take to recognize the cognitive impact of overdoses. New resources to support provider screening, assessment, and intervention will be introduced.
Presenter: Carolyn Lemsky, Ph.D.,C.Psych ABPP-CN
Moderator: Steve Wade, MBA - Consulting Executive Director, Brain Injury Association of America – Maine Chapter
About the webinar: This webinar is co-sponsored by the New England Prevention Technology Transfer Center, administered by AdCare Educational Institute of Maine, Inc. The New England Prevention Technology Transfer Center program is funded by SAMHSA of the U.S. Department of Health and Human Services (HHS). This webinar is planned in response to an identified need to provide training and information on brain injury and substance use disorders for New England (CT, ME, MA, NH, RI, VT) prevention professionals. The contents of New England PTTC programs are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by SAMHSA/HHS, or the U.S. Government.